Document is current
Any future updates will be listed below
-
Authors
Lamy, Elodie
Roquencourt, Camille
Zhou, Bingqing
Salvator, Hélène
Moine, Pierre
Annane, Djillali
Devillier, Philippe
Bardin, Emmanuelle
Grassin-Delyle, Stanislas https://orcid.org/0000-0001-5747-4432
-
Funding
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-18-RHUS-0004)
Agence Nationale de la Recherche (RHU4 RECORDS)
Agence Nationale de la Recherche (ANR-21-CO12-0004)
Agence Nationale de la Recherche (COVINOse)
Agence Nationale de la Recherche (ANR-23-IAHU-0004; IHU PROMETHEUS)
Agence Nationale de la Recherche (France 2030 prog)
Fondation Foch (VOC-Info)
Fondation Foch (VolatolHom)
Région Ile-de-France (DIM 1HEALTH 2019)
Région Ile-de-France (MeLoMane)
Région Ile-de-France (SESAME 2016)
Région Ile-de-France (VolatolHom)
- License Information
-
More Information
Article History
Received: 14 April 2024
Revised: 21 June 2024
Accepted: 25 June 2024
First Online: 9 July 2024
Declarations
:
: Breath samples were obtained from patients with COVID-19 enrolled in the RECORDS trial (NCT04280497). The study was approved by an ethics committee (Comite de Protection des Personnes EST I, Dijon, France; reference 20.03.10.51415).
: C.R., D.A. and S.G.D are named as inventors on a patent application covering breath analysis in COVID-19 (WO 2022/058796, A method for analysing a breath sample for screening, diagnosis or monitoring of SARS-CoV-2 carriage or infection (COVID-19) on humans). The authors declare no other competing interest.
